Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claus Garbe

Showing results (161-170 of 501) with videos related to

Pageof 51
Sort By:
The Lancet. Oncology|July 3, 2004
Malignant blue naevus of the scalpPeter Radny, Diana Berner, Thomas K Eigentler, et al.
The American Journal of Dermatopathology|May 23, 2008
Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 casesLuis Soares de Almeida, Luis Requena, Arno Rütten, et al.
Melanoma Research|August 3, 2013
S100B and lactate dehydrogenase as response and progression markers during treatment with vemurafenib in patients with advanced melanomaSail Abusaif, Zeinab Jradi, Laura Held, et al.
Medicine|September 15, 2017
The need for psycho-oncological support for melanoma patients: Central role of patients' self-evaluationSimone Mayer, Martin Teufel, Norbert Schaeffeler, et al.
Clinics in Dermatology|June 15, 2010
Incisional biopsy and melanoma prognosis: Facts and controversiesAnnette Pflugfelder, Benjamin Weide, Thomas Kurt Eigentler, et al.
European Journal of Pediatrics|November 26, 2002
Molecular diagnostics facilitate distinction between lethal and non-lethal subtypes of junctional epidermolysis bullosa: a case report and review of the literatureJürgen Bauer, Hauke Schumann, Karsten Sönnichsen, et al.
Oncotarget|May 7, 2016
Which melanoma patient carries a BRAF-mutation? A comparison of predictive modelsThomas Eigentler, Zeinab Assi, Jessica C Hassel, et al.
Pigment Cell & Melanoma Research|July 20, 2023
Histopathologic abundance of pigmentation correlates with disease-specific survival in malignant melanoma but is not independent of current AJCC pT stageValentin Aebischer, Amar Abu-Ghazaleh, Gisela Metzler, et al.
Cancer|August 16, 2006
The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003Konstantinos G Lasithiotakis, Ulrike Leiter, Roman Gorkievicz, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 27, 2019
S1-Leitlinie Dermatofibrosarcoma protuberans (DFSP) - Update 2018Selma Ugurel, Rolf-Dieter Kortmann, Peter Mohr, et al.
Pageof 51

Showing results (161-170 of 501) with videos related to

Sort By:
Pageof 51
The Lancet. Oncology|July 3, 2004
Malignant blue naevus of the scalpPeter Radny, Diana Berner, Thomas K Eigentler, et al.
The American Journal of Dermatopathology|May 23, 2008
Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 casesLuis Soares de Almeida, Luis Requena, Arno Rütten, et al.
Melanoma Research|August 3, 2013
S100B and lactate dehydrogenase as response and progression markers during treatment with vemurafenib in patients with advanced melanomaSail Abusaif, Zeinab Jradi, Laura Held, et al.
Medicine|September 15, 2017
The need for psycho-oncological support for melanoma patients: Central role of patients' self-evaluationSimone Mayer, Martin Teufel, Norbert Schaeffeler, et al.
Clinics in Dermatology|June 15, 2010
Incisional biopsy and melanoma prognosis: Facts and controversiesAnnette Pflugfelder, Benjamin Weide, Thomas Kurt Eigentler, et al.
European Journal of Pediatrics|November 26, 2002
Molecular diagnostics facilitate distinction between lethal and non-lethal subtypes of junctional epidermolysis bullosa: a case report and review of the literatureJürgen Bauer, Hauke Schumann, Karsten Sönnichsen, et al.
Oncotarget|May 7, 2016
Which melanoma patient carries a BRAF-mutation? A comparison of predictive modelsThomas Eigentler, Zeinab Assi, Jessica C Hassel, et al.
Pigment Cell & Melanoma Research|July 20, 2023
Histopathologic abundance of pigmentation correlates with disease-specific survival in malignant melanoma but is not independent of current AJCC pT stageValentin Aebischer, Amar Abu-Ghazaleh, Gisela Metzler, et al.
Cancer|August 16, 2006
The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003Konstantinos G Lasithiotakis, Ulrike Leiter, Roman Gorkievicz, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 27, 2019
S1-Leitlinie Dermatofibrosarcoma protuberans (DFSP) - Update 2018Selma Ugurel, Rolf-Dieter Kortmann, Peter Mohr, et al.
Pageof 51